Results from a small randomized controlled clinical trial show promising findings about a new type of therapy for patients ...

Axena Health, Inc., a women's health company redefining the standard of care for pelvic health conditions through clinically proven, non-invasive treatments, today announced a new publication entitled ...

A data-driven, collaborative program failed to lead to noticeable gains in the trial, but a researcher says the search isn’t ...

Utility of the 70-Gene MammaPrint Assay for Prediction of Benefit From Extended Letrozole Therapy in the NRG Oncology/NSABP B-42 Trial Patients with advanced lung cancer reporting at least moderate ...

The 58 participant, randomized, double-blind, placebo-controlled study was led by Edmarie Guzmán-Vélez, PhD, formerly an Assistant Professor in the Department of Psychiatry and the McCance Center for ...

A Nature Medicine study found that healthy Australian adults were widely exposed to plastic-associated chemicals, with ...

Treatment with GMRx2, a single pill combination of three low-dose blood pressure medicines, significantly reduced the risk of ...

Carica papaya leaf extract (CPLE) versus placebo to improve chemotherapy induced thrombocytopenia (CIT): Results of a phase III triple blinded, randomized placebo controlled trial (PACT study).

As a medical student and researcher, I was shocked by the brazen inequity of the trial.  Randomized controlled trials have ...

As of April 2026, more than 40 million GLP-1 receptor agonist prescriptions are dispensed annually in the United States alone ...